Skip to content
PeptideAgent

Calcitonin regulatory status

Current status of Calcitonin in the United States: FDA approved. In sport: Not WADA prohibited. Details, sources, and the dated timeline follow.

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What is the current status of Calcitonin?

Regulatory: FDA approvedWADA: Not WADA prohibitedVerified: Verified Sep 23, 2026
FDA and compounding
FDA approved as Calcimar and later Miacalcin injection in 1975 for Paget disease and hypercalcemia, with postmenopausal osteoporosis added, and as Miacalcin nasal spray in 1995 for osteoporosis; Fortical nasal spray (2005) and generic calcitonin-salmon nasal sprays followed. In March 2013 an FDA advisory committee reviewed the malignancy meta-analysis and the labels were revised to restrict osteoporosis use to women more than 5 years postmenopause for whom alternatives are not suitable and to require periodic reassessment. The European Medicines Agency withdrew nasal calcitonin for osteoporosis in 2012. Compounding is limited to patient specific needs because approved products exist.
WADA
Not WADA prohibited
Access path
  1. Prescription from a primary care provider, endocrinologist, or rheumatologist filled at a retail pharmacy (nasal spray) or given in clinic or hospital (injection).
  2. Not available through compounding or telehealth peptide clinics.

Full Calcitonin page: evidence, dosing in the literature, and sources

How has the status of Calcitonin changed over time?

No dated regulatory event has been recorded for Calcitonin. That usually means no FDA, PCAC, Federal Register, or WADA action has named it specifically. Category-wide actions are listed on the tracker hub.

Sources

Numbered citations in the answers above point here, followed by the regulatory sources on record for Calcitonin and the source of each dated event.

  1. [1]FDA: Questions and answers, changes to the indicated population for Miacalcin (calcitonin-salmon), 2013 malignancy meta-analysis (Wayback Machine capture of the FDA page, July 16, 2019)FDA, 2013
  2. [2]FDA prescribing information for Miacalcin (calcitonin salmon) injection, via DailyMedFDA, 2026
  3. [3]WADA Prohibited ListWADA, 2026
  4. [4]FDA prescribing information for calcitonin salmon nasal spray, via DailyMedFDA, 2026